![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Tracon to seek ‘strategic’ options; Ovid to lay off 17 workers
Plus, news about Merck, Orion, Tonix, Freeflow and Y-mAbs Therapeutics:
Tracon Pharmaceuticals seeks ‘strategic alternatives’ after PD-L1 fails Ph2 trial: In an 82-person sarcoma study …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.